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OBJECTIVES The aim of this work was to investigate the association between fish consumption and levels
of various inflammatory markers among adults without any evidence of cardiovascular disease.
BACKGROUND Fish consumption has been associated with reduced risk of coronary heart disease, but the
mechanisms have not been well understood or appreciated.
METHODS The ATTICA study is a cross-sectional survey that enrolled 1,514 men (age 18 to 87 years)
and 1,528 women (age 18 to 89 years) from the Attica region, Greece. Of them, 5% of men
and 3% of women were excluded due to a history of cardiovascular disease. Among others,
C-reactive protein (CRP), interleukin (IL)-6, tumor necrosis factor (TNF)-alpha, serum
amyloid A (SAA), and white blood cells (WBC) were measured, and dietary habits (including
fish consumption) were evaluated using a validated food frequency questionnaire.
RESULTS A total of 88% of men and 91% of women reported fish consumption at least once a month.
Compared to non-fish consumers, those who consumed 300 g of fish per week had on
average 33% lower CRP, 33% lower IL-6, 21% lower TNF-alpha, 28% lower SAA levels, and
4% lower WBC counts (all p  0.05). Significant results were also observed when lower
quantities (150 to 300 g/week) of fish were consumed. All associations remained significant
after various adjustments were made.
CONCLUSIONS Fish consumption was independently associated with lower inflammatory markers levels,
among healthy adults. The strength and consistency of this finding has implications for public
health and should be explored further. (J Am Coll Cardiol 2005;46:120–4) © 2005 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.03.048American College of Cardiology Foundation
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turrent scientific evidence suggests that diet plays a significant
ole in the prevention of cardiovascular diseases, while fish is
ne of the main components of a healthy diet. Epidemiological
tudies (1–4) and clinical trials (5,6) underline its beneficial
ffects in the prevention of coronary artery disease (CAD). On
he other hand, low-grade systemic inflammation participates
n the pathophysiology of CAD (7). Although there are some
etabolic studies and one epidemiological study that observed
eneficial effects of fish and its components on inflammatory
arkers (8–10), there are others that showed no effect (11–13).
herefore, we sought to evaluate the relationship between the
mount of fish consumed and the levels of various inflamma-
ory markers in a population-based sample of men and women
ithout any evidence of cardiovascular disease (the ATTICA
tudy) (14,15).
From the *Department of Nutrition and Dietetics, Harokopio University, Athens,
reece; †First Cardiology Clinic, School of Medicine, University of Athens, Athens,
reece; and ‡UND Life Sciences, Walpole, Massachusetts. The ATTICA study is
upported by research grants from the Hellenic Society of Cardiology (HCS2002).w
Manuscript received January 14, 2005; revised manuscript received March 12,
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opulation of the study. During 2001 to 2002, a total of
,518 men (age 46 13 years) and 1,524 women (age 45
3 years) agreed to participate (75% participation rate).
articipants could not exhibit clinical evidence of cardiovas-
ular or atherosclerotic disease or chronic viral infections,
nd they could not have cold or flu, acute respiratory
nfection, dental problems, or any type of surgery in the
eeks preceding the study (during the sampling none of the
articipants reported any of the aforementioned conditions
uring the last 6 to 10 weeks). The study design was
pproved by the Ethical Committee of the Department of
ardiology of Athens University Medical School.
ietary assessment. Dietary assessment was based on a
alidated food frequency questionnaire (FFQ) (16). Con-
umption of nonrefined cereals and products, vegetables,
egumes, fruits, olive oil, dairy products, fish, pulses, nuts,
otatoes, eggs, sweets, poultry, red meat and products, and
everages were measured as an average per week during the
ast year. Based on the FFQ, all participants were also asked
heir usual average frequency of fish consumption, which
as coded as follows: 0 for none or very rare (i.e., 4 U per
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July 5, 2005:120–4 Fish Consumption and Inflammationonth), 1 for rare (i.e., 4 U or about 150 g/week), 2 for
oderate (i.e., 4 to 12 U or 150 g to 300 g/week), and 3 for
requent (i.e., 12 U or 300 g/week). Finally, omega-3
ntake was also calculated based on a nutrient database.
iochemical analyses. During enrollment blood samples
ere collected after a 12-h overnight fast. C-reactive protein
CRP) and serum amyloid A (SAA) were assayed by
mmunonephelometry (Date-Behring Marburg GmbH,
arburg, Germany). Interleukin (IL)-6 was measured with
igh-sensitivity enzyme-linked immunoassay (R & D Sys-
ems Europe Ltd., Abingdon, United Kingdom). The intra-
nd inter-assay coefficient of variation was 5% for CRP
nd SAA and10% for IL-6. We used the ELISA method
or the quantitative determination of human tumor necro-
is factor (TNF)-alpha (Quantikine HS/human TNF-alpha
mmunoassay kit, R & D Systems, Inc., Minneapolis,
innesota). We also measured white blood cell (WBC)
ounts (Medicon analyzer, Medicon Ltd., Athens, Greece).
emographic, lifestyle, and clinical characteristics. The
tudy’s questionnaire also included sociodemographic infor-
ation about age, gender, average annual income during the
ast three years, and school-years. Moreover, current smok-
rs were defined as those who smoked daily at least one
igarette, former smokers were defined as those who had
topped smoking more than one year before entry (those
ho have stopped smoking within one year before enroll-
ent [i.e., 0.7%] were classified as smokers). The rest were
efined as nonsmokers. Then cigarette smoking was quan-
ified in number of cigarettes smoked per day, adjusted for
nicotine content of 0.8 mg/cigarette. Physical activity was
efined as leisure-time activity of a certain intensity and
uration, at least once a week during the past year. The rest
f the subjects were defined as sedentary. Body mass index
BMI) was calculated as weight (in kg) divided by standing
eight (in m2). Obesity was defined as BMI 29.9 kg/m2.
Moreover, patients whose average blood pressure levels
ere 140/90 mm Hg, or those under antihypertensive
edication, were classified as hypertensive. Hypercholester-
lemia was defined as total serum cholesterol levels 200
g/dl, or use of lipid-lowering agents. Diabetes mellitus
as defined as a blood glucose 125 mg/dl, or use of
ntidiabetic medications.
All participants were informed about the purposes of the
Abbreviations and Acronyms
BMI  body mass index
CAD  coronary artery disease
CRP  C-reactive protein
FFQ  food frequency questionnaire
IL  interleukin
SAA  serum amyloid A
TNF  tumor necrosis factor
WBC  white blood celltudy and agreed to participate. Further details about theethodologies used, measurements, and procedures have
een presented elsewhere (14,15).
tatistical analysis. Continuous variables are presented as
ean values  SD. Categorical variables are presented as
bsolute and relative frequencies. Associations between
ategorical variables were tested by the calculation of the
hi-square test. Correlations between inflammatory markers
nd other cofactors were evaluated by the use of Pearson’s or
pearman’s correlation coefficient. Comparisons between
ormally distributed continuous variables and fish-
onsuming groups were performed by one-way analysis of
ariance. The Kolmogorov-Smirnov test was applied to
ssess normality; CRP values were log-transformed due to
heir skewed distribution. In the case of years of school that
ould not be transformed to normal distributions, the
onparametric test suggested by Kruskal and Wallis was
sed. Differences in inflammation markers between sub-
roups according to fish consumption were tested using
ost-hoc analysis, after correcting the probability value for
ultiple comparisons using the Bonferroni rule. Multiple
egression models were then applied for all inflammatory
arkers on fish consumption, whereas fish interaction with
otential confounding factors was assessed by likelihood
atio tests. All reported p values were based on two-sided
ests. Statistical Package for Social Sciences software version
2.0 (SPSS Inc. 2002, Chicago, Illinois) was used for all the
tatistical calculations.
ESULTS
emographic and clinical characteristics of the par-
icipants. Eighty-eight percent of men and 91% of women
eported that they consume at least one unit of fish per
eek. Omega-3 fatty acid intake was 0.40  0.31 g/day in
en and 0.52  0.29 mg/day in women. Various demo-
raphic, clinical, and behavioral characteristics are presented
n Table 1. Moreover, consumption of fish was positively
orrelated with total energy intake and BMI (rho  0.08, p
0.01). However, the association between fish intake and
MI was mainly explained by the total daily energy intake
Table 1).
ish consumption and inflammatory markers. All in-
ammatory markers showed an inverse dose-response rela-
ionship with fish consumption (Table 2). Based on the
pplied post-hoc analysis, more prominent differences were
bserved when we compared high fish intake (i.e., 300 g
er week) with no consumption. Particularly, compared to
on-fish consumers, those who consumed 300 g of fish
er week had on average 33% lower CRP, 33% lower IL-6,
1% lower TNF-alpha, 28% lower SAA levels, and 4%
ower WBC counts. In addition, omega-3 intake was
nversely associated with the levels of CRP (r0.12, p
.001), IL-6 (r  0.09, p  0.002), TNF-alpha (r 
0.11, p  0.01), SAA (r  0.07, p  0.02), and WBC
r  0.08, p  0.03) (Table 2).
Furthermore, we observed that BMI was positively cor-
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Fish Consumption and Inflammation July 5, 2005:120–4elated with all inflammatory markers (at p  0.05), even
fter adjusting for physical activity and energy intake, but no
ifferences were observed regarding the effect of fish con-
umption on the investigated biomarkers when the data
ere stratified and analyzed by obesity status.
However, several potential confounders may influence the
revious associations. Therefore, we applied multiple re-
ression analysis, and adjusted R2 values were also included
o show the explanatory ability of the models. All inflam-
able 1. Participant Demographic, Lifestyle, and Clinical Charac
No. <1
en (n  1,514)
% of Participants 12%
Age (yrs) 44  12
Education status (yrs of school) 13  4
Current smokers (%) 50
Sedentary (%) 60
Obese (%) 18
Energy intake (kcal/day) 1,675  430 1,8
Hypertension (%) 41
Systolic blood pressure (mm Hg) 135  21 1
Diastolic blood pressure (mm Hg) 81  18
Hypercholesterolemia (%) 34
Total cholesterol (mg/dl) 209  41 1
HDL cholesterol (mg/dl) 44  11
Triglycerides (mg/dl) 185  41 1
Diabetes mellitus (%) 6
omen (n  1,528)
% of Participants 9%
Age (yrs) 44  11
Education status (yrs of school) 12  4
Current smokers (%) 35
Sedentary (%) 73
Obese (%) 15
Energy intake (kcal/day) 1,557  410 1,6
Hypertension (%) 45
Systolic blood pressure (mm Hg) 133  20 1
Diastolic blood pressure (mm Hg) 79  28
Hypercholesterolemia (%) 35
Total cholesterol (mg/dl) 211  40 1
HDL cholesterol (mg/dl) 53  13
Triglycerides (mg/dl) 188  45 1
Diabetes mellitus (%) 6
ata are expressed as mean  SD or percentages. For the evaluation of the tested hyp
tatus, obesity, hypertension, hypercholesterolemia, and diabetes), the analysis of varia
Bonferroni corrected) for the differences between fish consumption groups vs. no co
HDL  high-density lipoprotein.
able 2. Inflammatory Markers and Daily Fish Consumption
No. <150
umber of participants (%) 319 (11%) 1,719
-reactive protein (mg/l) 2.7  1.2 2.0 
nterleukin-6 (ng/ml) 1.5  0.5 1.3 
umor necrosis factor-alpha (mg/dl) 5.3  3 5.1 
myloid A (mg/dl) 6.4  4 5.9 
hite blood cells (1,000 counts) 6.8  3 6.7 
o gender differences were observed. *p  values derived from ANOVA that evaluate
actor). ‡p  0.05 and †p  0.01 (Bonferroni-corrected) for the differences between fish c
f variance (ANOVA).atory markers were still inversely associated with fish
onsumption, even after various adjustments were made.
omparing standardized beta coefficients (Table 3), we may
ee that the strongest associations between fish intake and
nflammatory markers were observed in CRP, IL-6, and
AA levels, followed by TNF-alpha and WBC counts
Table 3).
Furthermore, stratified analysis showed that fish and
mega-3 fatty acid intake were inversely associated with
ics
Fish Consumption
week 150–300 g/week >300 g/week p Value
24% 9% —
11* 55  12† 53  12† 0.001
2 11  4* 10  4 0.001
44 48 0.36
53 52 0.10
21 27† 0.03
420* 1,974  330† 2,200  330† 0.02
37* 27† 0.02
22 125  35* 124  25† 0.001
21 82  18 79  21 0.12
33 31 0.22
25 193  32 189  43 0.34
15 49  22 49  13 0.42
29 149  32 125  33 0.02
10 9 0.25
25% 8% —
12 53  11† 53  14† 0.001
3 11  3 9  3† 0.001
31 30 0.09
63 58 0.30
18* 25† 0.02
290 1,967  390† 2,100  340† 0.01
28† 21† 0.02
27* 124  25* 121  20† 0.001
22 84  21 78  22 0.21
37 33 0.34
22 190  22 182  33 0.29
11 51  21 52  16 0.32
32 145  33 131  32 0.03
7 10 0.13
s, we used the chi-square test for categorical variables (i.e., smoking, physical activity
r age, and the Kruskall-Wallis criterion for years of school. *p  0.05 and †p  0.01
ption. Probability values derived from the analysis of variance.
Fish Consumption
k 150–300 g/week >300 g/week p Value
) 745 (24%) 259 (9%) —
2.0  2.1† 1.8  1.1† 0.004
1.2  1.1† 1.0  0.3† 0.03
4.7  3† 4.2  2† 0.001
5.1  4‡ 4.6  3† 0.004
6.5  4‡ 6.5  3‡ 0.04
ssociations between inflammatory markers (dependent) and fish intake (independentterist
50 g/
55%
49 
12 
44
62
22
77 
43
28 
83 
37
97 
48 
68 
10
58%
48 
11 
38
65
18*
74 
32*
25 
82 
38
95 
52 
71 
7
othese
nce fog/wee
(56%
1.1†
0.6‡
2
4
4
d the a
onsumption groups vs. no consumption. Probability values derived from the analysis
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July 5, 2005:120–4 Fish Consumption and Inflammationower inflammatory markers levels in people with diabetes
nd hypertension, but not in people with hypercholesterol-
mia. Particularly, compared to non-fish consumers, dia-
etic people who ate300 g of fish per week had on average
0% to 25% lower levels of inflammatory markers (all p 
.05), whereas hypertensive subjects had on average 5% to
5% lower levels (all p  0.05).
Finally, cut-off point analysis showed that omega-3 fatty
cid intake of 0.6 g per day was the optimal level that
aximized the likelihood of having the levels of the inflam-
atory markers in the lowest or middle tertile.
ISCUSSION
e studied a population-based sample of 3,042 adult men
nd women, and we observed a strong inverse relationship
etween fish consumption and levels of inflammatory mark-
rs related to cardiovascular disease, irrespective of other
otential confounders. We have also expanded findings
rom previous works by showing that omega-3 fatty acid
ntake was inversely associated with inflammatory markers.
oreover, daily consumption of 0.6 g of omega-3 fatty
cids seems to be the optimal level that is associated with
he maximum reduction in inflammatory markers levels.
The effect of fish and omega-3 fatty acid intake on
ardiovascular disease has long been discussed (17–20). The
enefits from its intake on the cardiovascular system have
een, in part, attributed to their effect on lipoprotein levels,
oagulation process, as well as immune response and hyper-
ension status (2). We found that fish intake is associated
ith decreased levels of proinflammatory markers. It may be
ypothesized that fish intake increases IL-6 synthesis,
hich then affects CRP and SAA production in the liver.
umor necrosis factor is also involved in the acute-phase
rotein synthesis, but it has been suggested that only IL-6
an stimulate synthesis of all acute-phase proteins involved
n the inflammatory response (21). Therefore, because fish
onsumption is associated with decreased concentrations of
hese proinflammatory markers, it is reasonable to suggest
hat regular fish intake suppresses inflammation and, thus,
roduces its beneficial actions in human health.
However, metabolic studies gave conflicting results. On
he one hand, Ciubotaru et al. (8) suggested that intake of
able 3. Inflammatory Markers and Fish Consumption (in g/We
Inflammatory Markers
Standardized Beta
Coefficient
-reactive protein (mg/l) 0.057
nterleukin-6 (ng/ml) 0.051
myloid A (mg/dl) 0.044
umor necrosis factor-alpha (mg/dl) 0.036
hite blood cell (1,000 counts) 0.009
p  values derived from multiple linear regression models that evaluated the associat
or age in years, gender, pack-years of smoking, physical activity status (sedentary,
ressures in mm Hg, total, low-density lipoprotein, and high-density lipoprotein chole
f the food groups included food frequency questionnaire.sh oils decreased CRP and IL-6 levels in postmenopausalomen. In addition, Trebble et al. (9) observed a decrease in
NF-alpha and IL-6 peripheral blood mononuclear cell
roduction with increasing omega-3 fatty acid intake and
lso a tendency toward a “U-shaped” dose response with the
owest cytokine production at 1.0 g/day omega-3 fatty acid
upplementation. On the other hand, when fish oil supple-
entation was given in more physiological levels, no statis-
ical differences were found (10–12). In the present work,
tudying a “free-eating” population, the optimal intake for
aximal reduction in the inflammation process was found
o be 0.6 g of omega-3 fatty acids per day. We could
ypothesize that the benefit is more pronounced if omega-3
atty acids are consumed in the form of fish rather than in
he form of a supplement and that in the metabolic studies,
t is easier to detect differences in the sites of production,
uch as peripheral blood mononuclear cells rather than in
lasma.
Some limitations in our study may exist. For example, the
esign of the study is cross-sectional and, therefore, we
annot make assumptions for causal relationships. The
lood sampling was performed only at one visit. Fish intake
as evaluated by self-reports through FFQs, and, therefore,
nformation about the amount of fish consumed could be
ver- or underestimated. Another limitation is the small
umber of individuals who consumed 300 g/week of fish.
In spite of the lack of causal relationships, based on our
ndings and those of others, it is reasonable to conclude that
sh consumption is associated with reduced inflammatory
arker levels and, thus, is of benefit in the prevention of
AD, irrespective of known confounding factors.
eprint requests and correspondence: Dr. Demosthenes B.
anagiotakos, 46 Paleon Polemiston St., Glyfada, Attica, 166 74,
reece. E-mail: d.b.panagiotakos@usa.net.
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